Discover how to benefit from:
Translational Pharmaceutics accelerates drug development by integrating formulation development, real-time manufacturing and clinical testing. Over the past decade it has been used widely by pharmaceutical and biotech companies on >400 programs to advance molecules across the full development cycle from first-in-human trials to market (FIH) Key applications within development process include:
The Tufts Center for the Study of Drug Development (CSDD) compared the cycle times of traditional drug development programs to Translational Pharmaceutics programs and their derivative effects on development economics. These data were incorporated in a drug development model and the financial benefits were quantified on industry R&D costs and returns. The model assessed several different project types and the top line results included mean financial benefits exceeding $100 million and mean timeline savings of >12 months.